SEER peer analysis
Seer (SEER) against its competitors: price, today's move, 1-year return and market value side by side.
- SEER's peers: ANTX (AN2 Therapeutics), CCCC (C4 Therapeutics), CGEM (Cullinan Therapeutics), FHTX (Foghorn Therapeutics), GLUE (Monte Rosa Therapeutics), HCWB (HCW Biologics), KYMR (Kymera Therapeutics), LYEL (Lyell Immunopharma).
SEER and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ANTX AN2 Therapeutics | $5.10 | -2.30% | 383.33% | $198.07M |
| CCCC C4 Therapeutics | $2.37 | -2.86% | -5.19% | $311.26M |
| CGEM Cullinan Therapeutics | $8.96 | -1.21% | 6.04% | $581.69M |
| FHTX Foghorn Therapeutics | $1.66 | -6.74% | -65.84% | $99.54M |
| GLUE Monte Rosa Therapeutics | $8.64 | -3.03% | -38.90% | $738.29M |
| HCWB HCW Biologics | $0.74 | -3.77% | -93.87% | $2.31M |
| KYMR Kymera Therapeutics | $124.06 | 3.91% | 91.39% | $10.59B |
| LYEL Lyell Immunopharma | $13.80 | 1.62% | -19.86% | $339.28M |
| MLYS Mineralys Therapeutics | $13.70 | -3.25% | -67.47% | $1.21B |
| MNOV MediciNova | $1.27 | -4.51% | -11.19% | $65.07M |
| MOLN Molecular Partners | $2.67 | -6.82% | – | $102.16M |
| NKTX Nkarta | $1.15 | 2.68% | -35.75% | $82.37M |
| NRIX Nurix Therapeutics | $12.85 | -5.51% | -10.33% | $1.40B |
| ORIC Oric | $7.37 | -4.29% | -35.80% | $765.98M |
| PEPG PepGen | $3.79 | -3.56% | -31.46% | $262.50M |
| PHVS Pharvaris | $31.28 | -1.20% | 27.47% | $2.21B |
| SEER Seer | $1.39 | -3.82% | -30.75% | $77.30M |